The advancement of microneedles by 3M and their partnership with pharmaceuticals to allow the tool for in-home use. This will give difficult to deliver medicines the ability to be self-administered and become more effective.

AstraZeneca PLC unveiled agreements that should enable the pharmaceutical company to tap into a promising, nascent gene technology aimed at making drugs more precise. AstraZeneca said it hopes the technology will help it accelerate the discovery of new treatments, a process that normally takes years.

Advancements toward utilizing mobile based apps which can currently monitor insulin levels for those who suffer from diabetes to a fully automated system which can maintain the proper insulin needed in the body as a true artificial pancreas.

Advancement of wearable adhesive bandages that can monitor a multitude of different information. From a baby's temperature, to athletes training regimen. The wearable tech connects through bluetooth technology to send the data they collect to your mobile device for review.

Big pharma and CROs looking to exploit wearable technology in clinical trials. Novartis announced an alliance with Qualcomm Life to use its cloud-based 2net platform to collect medical device data during in-home remote monitoring of clinical trial participants.